50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
NASDAQ:PSTV

Plus Therapeutics - PSTV News Today

$0.48
-0.02 (-4.00%)
(As of 09/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.46
$0.49
50-Day Range
$0.47
$1.00
52-Week Range
$0.39
$2.16
Volume
193,547 shs
Average Volume
2.57 million shs
Market Capitalization
$10.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Get Plus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter.



PSTV Media Mentions By Week

PSTV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PSTV
News Sentiment

1.36

0.80

Average
Medical
News Sentiment

PSTV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PSTV Articles
This Week

4

1

PSTV Articles
Average Week

SourceHeadline
seekingalpha.com logoPSTV Plus Therapeutics, Inc.
seekingalpha.com - September 28 at 11:23 PM
finance.yahoo.com logoWhy Are Plus Therapeutics Shares Gaining Today?
finance.yahoo.com - September 22 at 1:40 PM
finance.yahoo.com logoPlus Therapeutics Executes $17.6 Million Award Contract with Cancer Prevention & Research Institute of Texas
finance.yahoo.com - September 22 at 8:39 AM
finance.yahoo.com logoPlus Therapeutics to Present In-Person at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 8 at 8:22 AM
finance.yahoo.com logoPlus Therapeutics Announces Summary of FDA Meeting on Company’s cGMP Manufacturing Process for Lead Drug Candidate
finance.yahoo.com - August 29 at 10:35 AM
finance.yahoo.com logoPlus Therapeutics to Present Data from ReSPECT-GBM™ Clinical Trial at the European Society for Medical Oncology Congress 2022
finance.yahoo.com - August 23 at 5:09 PM
finance.yahoo.com logoFunding wrap: Plus Therapeutics lands nearly $18M from CPRIT
finance.yahoo.com - August 22 at 2:46 PM
finance.yahoo.com logoPlus Therapeutics Shares Surge On Positive Data From Lead Brain Cancer Candidate
finance.yahoo.com - August 16 at 11:28 AM
investorplace.com logoWhy Is Plus Therapeutics (PSTV) Stock Up 38% Today?
investorplace.com - August 15 at 2:08 PM
seekingalpha.com logoPlus Therapeutics stock soars 59% as 186RNL shows promise in brain cancer trials
seekingalpha.com - August 15 at 7:43 AM
finance.yahoo.com logoPlus Therapeutics Announces Share Repurchase Program
finance.yahoo.com - August 15 at 7:43 AM
finance.yahoo.com logoPlus Therapeutics Presents Positive Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases
finance.yahoo.com - August 13 at 3:27 PM
finance.yahoo.com logoPlus Therapeutics to Present Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases
finance.yahoo.com - July 28 at 9:29 AM
finance.yahoo.com logoPlus Therapeutics to Present at Inaugural Targeted Radiopharmaceuticals Summit
finance.yahoo.com - July 27 at 8:27 AM
finance.yahoo.com logoPlus Therapeutics to Announce Second Quarter 2022 Financial Results and Host Conference Call on July 21, 2022
finance.yahoo.com - July 13 at 8:52 AM
finance.yahoo.com logoPlus Therapeutics Successfully Completes Key Milestone for cGMP Manufacture of Lead Investigational Radiotherapeutic
finance.yahoo.com - July 12 at 7:41 AM
seekingalpha.com logoPlus Therapeutics inks contract to use Biocept's test for use in cancer trial
seekingalpha.com - June 22 at 3:03 PM
finance.yahoo.com logoPlus Therapeutics Completes Enrollment of Cohort 1 ReSPECT-LM Phase 1/2a Trial
finance.yahoo.com - June 16 at 8:40 AM
finance.yahoo.com logoPlus Therapeutics Reports Positive Clinical Outcomes from ReSPECT-GBM Trial at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting
finance.yahoo.com - June 13 at 8:44 AM
finance.yahoo.com logoPlus Therapeutics to Present at the 2022 Q2 Investor Summit
finance.yahoo.com - April 26 at 10:44 AM
seekingalpha.com logoPlus Therapeutics GAAP EPS of -$0.19 misses by $0.01
seekingalpha.com - April 21 at 7:34 PM
finance.yahoo.com logoPlus Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
finance.yahoo.com - April 21 at 7:34 PM
seekingalpha.com logoPlus Therapeutics Q1 2022 Earnings Preview
seekingalpha.com - April 20 at 6:22 PM
finance.yahoo.com logoPlus Therapeutics to Announce First Quarter 2022 Financial Results and Host Conference Call on April 21, 2022
finance.yahoo.com - April 14 at 9:53 AM
finance.yahoo.com logoPlus Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting
finance.yahoo.com - April 8 at 8:29 PM
finance.yahoo.com logoPlus Therapeutics and Medidata Announce Expanded Clinical Trial Partnership
finance.yahoo.com - April 5 at 10:28 AM
finance.yahoo.com logoPlus Therapeutics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
finance.yahoo.com - March 23 at 9:28 AM
finance.yahoo.com logoPlus Therapeutics Announces First Patient Dosed in Phase 1/2a Dose Escalation Trial of 186RNL Radiotherapeutic for Leptomeningeal Metastases
finance.yahoo.com - March 22 at 7:42 AM
finance.yahoo.com logoPlus Therapeutics Announces Upcoming Participation at the 2022 SNMMI Therapeutics Conference
finance.yahoo.com - March 3 at 10:30 AM
seekingalpha.com logoPlus Therapeutics GAAP EPS of -$1.11 misses by $0.01
seekingalpha.com - February 26 at 10:47 PM
benzinga.com logoRecap: Plus Therapeutics Q4 Earnings
benzinga.com - February 24 at 8:22 PM
finance.yahoo.com logoPlus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
finance.yahoo.com - February 24 at 8:22 PM
seekingalpha.com logoPlus Therapeutics Q4 2021 Earnings Preview
seekingalpha.com - February 24 at 8:41 AM
finance.yahoo.com logoPlus Therapeutics Partners with Medidata to Apply Innovative Synthetic Control ArmⓇ Solution to Accelerate Brain Cancer Clinical Trial
finance.yahoo.com - February 22 at 7:32 PM
finance.yahoo.com logoPlus Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 24, 2022
finance.yahoo.com - February 18 at 9:16 AM
finance.yahoo.com logoPlus Therapeutics to Present at BIO CEO & Investor Conference
finance.yahoo.com - February 7 at 11:01 AM
nasdaq.com logoPLUS THERAPEUTICS, Inc. Common Stock (PSTV)
nasdaq.com - January 24 at 8:29 PM
finance.yahoo.com logoPlus Therapeutics Expands Investigational Oncology Drug Pipeline
finance.yahoo.com - January 6 at 1:54 PM
seekingalpha.com logoPlus Therapeutics in pact with University of Texas for cancer therapeutics
seekingalpha.com - January 6 at 8:54 AM
finance.yahoo.com logoPlus Therapeutics Significantly Expands Investigational Oncology Drug Pipeline
finance.yahoo.com - January 6 at 8:54 AM
finance.yahoo.com logoPlus Therapeutics Shares Shine After Two Milestones To Manufacture Its Lead Radiotherapeutic
finance.yahoo.com - January 4 at 11:25 AM
finance.yahoo.com logoPlus Therapeutics to Present at MedInvest Oncology Investor Conference
finance.yahoo.com - December 2 at 8:31 AM
finance.yahoo.com logoIs Plus Therapeutics (NASDAQ:PSTV) A Risky Investment?
finance.yahoo.com - November 22 at 12:34 PM
finance.yahoo.com logoPlus Therapeutics' Targeted Radiotherapy Shows Encouraging Overall Survival In Brain Tumour Trial
finance.yahoo.com - November 18 at 5:55 PM
finance.yahoo.com logoPlus Therapeutics Announces New Employment Inducement Grants
finance.yahoo.com - November 12 at 8:13 AM
finance.yahoo.com logoPlus Therapeutics Receives FDA Fast Track Designation for 186RNL Targeted Radiotherapeutic for Leptomeningeal Metastases
finance.yahoo.com - November 9 at 7:41 AM
finance.yahoo.com logoPlus Therapeutics to Host Key Opinion Leader Roundtable on ReSPECT™-GBM Trial
finance.yahoo.com - November 3 at 8:15 AM
finance.yahoo.com logoPlus Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
finance.yahoo.com - October 21 at 8:16 PM
finance.yahoo.com logoPlus Therapeutics Announces FDA Clearance of Investigational New Drug Application for 186RNL for the Treatment of Leptomeningeal Metastases
finance.yahoo.com - October 19 at 7:35 AM
finance.yahoo.com logoPlus Therapeutics to Announce Third Quarter 2021 Financial Results and Host Conference Call on October 21, 2021
finance.yahoo.com - October 14 at 8:27 AM
Get Plus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:PSTV) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.